{"id":3130,"date":"2019-09-02T04:49:38","date_gmt":"2019-09-02T04:49:38","guid":{"rendered":"http:\/\/www.getbetterbodysystem.com\/fat-loss-tips\/patent-court-to-review-alexions-soliris-patents-on-amgen-challenge\/"},"modified":"2019-09-02T04:49:38","modified_gmt":"2019-09-02T04:49:38","slug":"patent-court-to-review-alexions-soliris-patents-on-amgen-challenge","status":"publish","type":"post","link":"http:\/\/www.getbetterbodysystem.com\/fat-loss-tips\/patent-court-to-review-alexions-soliris-patents-on-amgen-challenge\/","title":{"rendered":"Patent court to review Alexion’s Soliris patents on Amgen challenge"},"content":{"rendered":"
The U.S. patent office will review patents on Alexion Pharmaceuticals Inc’s blood disorder treatment Soliris, after Amgen Inc challenged them, court filings showed on Friday.<\/p>\n